Survival after pleural malignant mesothelioma: a population-based study in Italy
- PMID: 12400973
- DOI: 10.1177/030089160208800403
Survival after pleural malignant mesothelioma: a population-based study in Italy
Abstract
Aims and background: The study analyzed survival after malignant mesothelioma in the population-based Registry of Malignant Mesothelioma of Piedmont (NW Italy, 4.5 million total population). It focused on possible differences related to period of diagnosis a proxy of changes in diagnostic or therapeutic procedures.
Methods: Cases were actively searched in pathology units and files of hospital admissions and discharges. In 1990-1998, 693 incident cases were diagnosed in residents in the region: 590 of them had a histologic diagnosis of pleural mesothelioma in life and were included in the study. Vital status was ascertained at the municipality of residence as of January 1, 2000.
Results: Fifty-eight cases were alive (9.8%) and 20 were lost (3.6%) at the end of the follow-up. Median survival was 0.71 years (95% CI, 0.64-0.78). Cumulative survival was 35.9% at 1 year (95% CI, 32.0-39.8) and 14.2% at 2 years (95% CI, 11.2-17.1). Survival was associated to age (longer survival for younger subjects at diagnosis; P <0.0001) and to histology (longer survival for epithelial mesothelioma, shorter for fibrous and intermediate for mixed or unspecified types; P <0.0001). There was no difference in survival for period of diagnosis. The results were confirmed in multivariate analyses. Analyses according to type of hospital (with vs without thoracic surgery) did not show any statistically significant difference.
Discussion: The study on survival after malignant mesothelioma is the second largest of the three population-based studies in the world, which showed results similar to ours. Survival measured in published clinical series ranged between 18.4% and 57.6% at 1 year for pleural and 24.1% and 33.8% for peritoneal mesothelioma. The most striking effect of the present study was the absence of improvement in survival with period of diagnosis. Either there was no change in treatment efficacy or the effect was limited to small subgroups and could not be noticed when the analysis included larger categories.
Similar articles
-
Survival of malignant pleural mesothelioma cases in the Tuscan Mesothelioma Register, 1988-2000: a population-based study.Eur J Cancer Prev. 2005 Jun;14(3):195-9. doi: 10.1097/00008469-200506000-00001. Eur J Cancer Prev. 2005. PMID: 15901986
-
Survival of pleural malignant mesothelioma in Italy: a population-based study.Int J Cancer. 2009 Jan 1;124(1):201-7. doi: 10.1002/ijc.23874. Int J Cancer. 2009. PMID: 18792097
-
Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006.Tumori. 2012 Mar-Apr;98(2):215-9. doi: 10.1177/030089161209800206. Tumori. 2012. PMID: 22677987
-
Clinical Features and Treatment Outcome of Malignant Pleural Mesothelioma.Oncol Res Treat. 2017;40(6):364-369. doi: 10.1159/000464410. Epub 2017 May 9. Oncol Res Treat. 2017. PMID: 28472807 Review.
-
Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience.J Clin Oncol. 1998 Jan;16(1):145-52. doi: 10.1200/JCO.1998.16.1.145. J Clin Oncol. 1998. PMID: 9440736 Review.
Cited by
-
Asbestos related diseases in Italy: an integrated approach to identify unexpected professional or environmental exposure risks at municipal level.Int Arch Occup Environ Health. 2008 Aug;81(8):993-1001. doi: 10.1007/s00420-007-0293-x. Epub 2007 Dec 20. Int Arch Occup Environ Health. 2008. PMID: 18094988
-
A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma.Photochem Photobiol. 2019 Jan;95(1):411-418. doi: 10.1111/php.13065. Epub 2018 Dec 28. Photochem Photobiol. 2019. PMID: 30485442 Free PMC article.
-
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.J Surg Res. 2015 Jun 1;196(1):23-32. doi: 10.1016/j.jss.2015.01.043. Epub 2015 Jan 29. J Surg Res. 2015. PMID: 25791825 Free PMC article.
-
Impact of guideline therapy on survival of patients with stage I-III epithelioid mesothelioma.J Thorac Dis. 2023 Dec 30;15(12):6661-6673. doi: 10.21037/jtd-23-1334. Epub 2023 Dec 26. J Thorac Dis. 2023. PMID: 38249900 Free PMC article.
-
Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia.Occup Environ Med. 2004 Apr;61(4):e14. doi: 10.1136/oem.2003.008128. Occup Environ Med. 2004. PMID: 15031405 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical